Skip to content

Gender Differences in Parkinsonian Patients- a Swedish Register Study

Gender Differences in Diagnostic Tools, Medication, Time to Medication and Non-motor Symptoms in Parkinsonian Patients- a Swedish Register Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04713306
Enrollment
1217
Registered
2021-01-19
Start date
2006-01-01
Completion date
2019-12-31
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

NonMotorSymptoms, medication, National Registries

Brief summary

BACKGROUND: The complex impact of gender has been studied in different perspectives of health and disease in the literature. However, few attempts have been made to compile data from systematic disease specific registrations Swedish National Quality Registers play an important role in collecting large amounts of diagnose specific data, symptoms, and treatments. The subset Parkinson Registry has been in use for more than 20 years and are represented in all counties and hospitals where neurological care is provided in Sweden and offer optimal conditions to describe gender specific differences in the use of diagnostic tools, lead times and symptom profiles.

Detailed description

Aim: To study differences between gender in diagnostic tools, pharmacological interventions, and self-reported symptoms in Parkinson´s Disease (PD). METHODS: Data were extracted from the Swedish Neuro Registers, one of the Swedish National Quality Registers. A mix of urban and rural parts of the country were chosen and data were divided by gender. Self-reported first experienced PD related symptom was used to define the starting point when processing the data. Zero to three years from this point was defined as early symptoms and over three years as late symptoms. CONCLUSION: Differences between gender were seen in all chosen aspects, both diagnostically. Distinctions were also prominent in reported NonMotorSymptoms (NMS) profiles. These findings should be important to take into consideration for patients, professional staff, and caregivers in the daily work with gender mixed PD groups.

Interventions

None listed

Sponsors

Jonkoping University
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
Region Jönköping County
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
1 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Participants registered in the Swedish Neuro Registers. * Parkinson´s Disease * Acceptance of extraction of data

Exclusion criteria

* non parkinsonian patients * Participants in the Registries who have not given allowance of extraction of data.

Design outcomes

Primary

MeasureTime frameDescription
Differences between gender2006-2020investigations, medications,NonMotorSymptoms

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026